nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00326	0.00326	CcSEcCtD
Gadobutrol—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Gadobutrol—Infection—Sitagliptin—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Gadobutrol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00324	0.00324	CcSEcCtD
Gadobutrol—Vomiting—Acarbose—type 2 diabetes mellitus	0.00323	0.00323	CcSEcCtD
Gadobutrol—Rash—Acarbose—type 2 diabetes mellitus	0.00321	0.00321	CcSEcCtD
Gadobutrol—Dermatitis—Acarbose—type 2 diabetes mellitus	0.0032	0.0032	CcSEcCtD
Gadobutrol—Insomnia—Glipizide—type 2 diabetes mellitus	0.00318	0.00318	CcSEcCtD
Gadobutrol—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00317	0.00317	CcSEcCtD
Gadobutrol—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00315	0.00315	CcSEcCtD
Gadobutrol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00314	0.00314	CcSEcCtD
Gadobutrol—Nausea—Tolazamide—type 2 diabetes mellitus	0.00314	0.00314	CcSEcCtD
Gadobutrol—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00314	0.00314	CcSEcCtD
Gadobutrol—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00313	0.00313	CcSEcCtD
Gadobutrol—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00313	0.00313	CcSEcCtD
Gadobutrol—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00312	0.00312	CcSEcCtD
Gadobutrol—Rash—Nateglinide—type 2 diabetes mellitus	0.00309	0.00309	CcSEcCtD
Gadobutrol—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00309	0.00309	CcSEcCtD
Gadobutrol—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00304	0.00304	CcSEcCtD
Gadobutrol—Nausea—Acarbose—type 2 diabetes mellitus	0.00302	0.00302	CcSEcCtD
Gadobutrol—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00302	0.00302	CcSEcCtD
Gadobutrol—Pain—Glipizide—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Gadobutrol—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Gadobutrol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00296	0.00296	CcSEcCtD
Gadobutrol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00296	0.00296	CcSEcCtD
Gadobutrol—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00294	0.00294	CcSEcCtD
Gadobutrol—Infection—Bromocriptine—type 2 diabetes mellitus	0.00294	0.00294	CcSEcCtD
Gadobutrol—Pollakiuria—Losartan—type 2 diabetes mellitus	0.00293	0.00293	CcSEcCtD
Gadobutrol—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00292	0.00292	CcSEcCtD
Gadobutrol—Nausea—Nateglinide—type 2 diabetes mellitus	0.00291	0.00291	CcSEcCtD
Gadobutrol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.0029	0.0029	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.00287	0.00287	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00287	0.00287	CcSEcCtD
Gadobutrol—Convulsion—Glyburide—type 2 diabetes mellitus	0.00287	0.00287	CcSEcCtD
Gadobutrol—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.00284	0.00284	CcSEcCtD
Gadobutrol—Pain—Sitagliptin—type 2 diabetes mellitus	0.00279	0.00279	CcSEcCtD
Gadobutrol—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00278	0.00278	CcSEcCtD
Gadobutrol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00275	0.00275	CcSEcCtD
Gadobutrol—Vomiting—Repaglinide—type 2 diabetes mellitus	0.0027	0.0027	CcSEcCtD
Gadobutrol—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Gadobutrol—Rash—Repaglinide—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Gadobutrol—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.00268	0.00268	CcSEcCtD
Gadobutrol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Gadobutrol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Gadobutrol—Headache—Repaglinide—type 2 diabetes mellitus	0.00266	0.00266	CcSEcCtD
Gadobutrol—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00266	0.00266	CcSEcCtD
Gadobutrol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00265	0.00265	CcSEcCtD
Gadobutrol—Sweating increased—Ramipril—type 2 diabetes mellitus	0.00265	0.00265	CcSEcCtD
Gadobutrol—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.00264	0.00264	CcSEcCtD
Gadobutrol—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00264	0.00264	CcSEcCtD
Gadobutrol—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00263	0.00263	CcSEcCtD
Gadobutrol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00261	0.00261	CcSEcCtD
Gadobutrol—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.0026	0.0026	CcSEcCtD
Gadobutrol—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Gadobutrol—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Gadobutrol—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00258	0.00258	CcSEcCtD
Gadobutrol—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00258	0.00258	CcSEcCtD
Gadobutrol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Gadobutrol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Gadobutrol—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Gadobutrol—Nausea—Repaglinide—type 2 diabetes mellitus	0.00252	0.00252	CcSEcCtD
Gadobutrol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00251	0.00251	CcSEcCtD
Gadobutrol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00248	0.00248	CcSEcCtD
Gadobutrol—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00248	0.00248	CcSEcCtD
Gadobutrol—Vertigo—Valsartan—type 2 diabetes mellitus	0.00246	0.00246	CcSEcCtD
Gadobutrol—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00244	0.00244	CcSEcCtD
Gadobutrol—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Gadobutrol—Vertigo—Orlistat—type 2 diabetes mellitus	0.00243	0.00243	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00242	CcSEcCtD
Gadobutrol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00242	0.00242	CcSEcCtD
Gadobutrol—Palpitations—Valsartan—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Gadobutrol—Infection—Gliclazide—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Gadobutrol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Gadobutrol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00241	0.00241	CcSEcCtD
Gadobutrol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.0024	0.0024	CcSEcCtD
Gadobutrol—Palpitations—Orlistat—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Gadobutrol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00238	0.00238	CcSEcCtD
Gadobutrol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00235	0.00235	CcSEcCtD
Gadobutrol—Convulsion—Orlistat—type 2 diabetes mellitus	0.00234	0.00234	CcSEcCtD
Gadobutrol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00234	0.00234	CcSEcCtD
Gadobutrol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00234	0.00234	CcSEcCtD
Gadobutrol—Dizziness—Glipizide—type 2 diabetes mellitus	0.00232	0.00232	CcSEcCtD
Gadobutrol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.0023	0.0023	CcSEcCtD
Gadobutrol—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.0023	0.0023	CcSEcCtD
Gadobutrol—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00228	0.00228	CcSEcCtD
Gadobutrol—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00225	0.00225	CcSEcCtD
Gadobutrol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00224	0.00224	CcSEcCtD
Gadobutrol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00224	0.00224	CcSEcCtD
Gadobutrol—Vomiting—Glipizide—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Gadobutrol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Gadobutrol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00223	0.00223	CcSEcCtD
Gadobutrol—Infection—Valsartan—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Gadobutrol—Rash—Glipizide—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Gadobutrol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Gadobutrol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Gadobutrol—Headache—Glipizide—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Gadobutrol—Palpitations—Metformin—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Gadobutrol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Gadobutrol—Infection—Orlistat—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Gadobutrol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00218	0.00218	CcSEcCtD
Gadobutrol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00217	0.00217	CcSEcCtD
Gadobutrol—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00216	0.00216	CcSEcCtD
Gadobutrol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00216	0.00216	CcSEcCtD
Gadobutrol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00216	0.00216	CcSEcCtD
Gadobutrol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00214	0.00214	CcSEcCtD
Gadobutrol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00213	0.00213	CcSEcCtD
Gadobutrol—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00211	0.00211	CcSEcCtD
Gadobutrol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00211	0.00211	CcSEcCtD
Gadobutrol—Visual impairment—Ramipril—type 2 diabetes mellitus	0.0021	0.0021	CcSEcCtD
Gadobutrol—Nausea—Glipizide—type 2 diabetes mellitus	0.00209	0.00209	CcSEcCtD
Gadobutrol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00208	0.00208	CcSEcCtD
Gadobutrol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00208	0.00208	CcSEcCtD
Gadobutrol—Pain—Gliclazide—type 2 diabetes mellitus	0.00208	0.00208	CcSEcCtD
Gadobutrol—Rash—Glimepiride—type 2 diabetes mellitus	0.00207	0.00207	CcSEcCtD
Gadobutrol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00206	0.00206	CcSEcCtD
Gadobutrol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00206	0.00206	CcSEcCtD
Gadobutrol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00206	0.00206	CcSEcCtD
Gadobutrol—Headache—Glimepiride—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Gadobutrol—Headache—Sitagliptin—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Gadobutrol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Gadobutrol—Infection—Metformin—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Gadobutrol—Insomnia—Valsartan—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Gadobutrol—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Gadobutrol—Insomnia—Orlistat—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Gadobutrol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Gadobutrol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Gadobutrol—Vertigo—Losartan—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Gadobutrol—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Gadobutrol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Gadobutrol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Gadobutrol—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Gadobutrol—Palpitations—Losartan—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Gadobutrol—Nausea—Glimepiride—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Gadobutrol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Gadobutrol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Gadobutrol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Gadobutrol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Gadobutrol—Infection—Irbesartan—type 2 diabetes mellitus	0.0019	0.0019	CcSEcCtD
Gadobutrol—Pain—Orlistat—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Gadobutrol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Gadobutrol—Rash—Bromocriptine—type 2 diabetes mellitus	0.00186	0.00186	CcSEcCtD
Gadobutrol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00186	0.00186	CcSEcCtD
Gadobutrol—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00186	0.00186	CcSEcCtD
Gadobutrol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Gadobutrol—Headache—Bromocriptine—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Gadobutrol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Gadobutrol—Dry mouth—Losartan—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Gadobutrol—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Gadobutrol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00181	0.00181	CcSEcCtD
Gadobutrol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Gadobutrol—Infection—Losartan—type 2 diabetes mellitus	0.00179	0.00179	CcSEcCtD
Gadobutrol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00179	0.00179	CcSEcCtD
Gadobutrol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Gadobutrol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00176	0.00176	CcSEcCtD
Gadobutrol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Gadobutrol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Gadobutrol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Gadobutrol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Gadobutrol—Vomiting—Glyburide—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Gadobutrol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Gadobutrol—Rash—Glyburide—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadobutrol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadobutrol—Vertigo—Ramipril—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Gadobutrol—Headache—Glyburide—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Gadobutrol—Palpitations—Ramipril—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Gadobutrol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Gadobutrol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadobutrol—Convulsion—Ramipril—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadobutrol—Pain—Irbesartan—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Gadobutrol—Insomnia—Losartan—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Gadobutrol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Gadobutrol—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Gadobutrol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadobutrol—Nausea—Glyburide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadobutrol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadobutrol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Gadobutrol—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Gadobutrol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Gadobutrol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Gadobutrol—Pain—Losartan—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Gadobutrol—Rash—Gliclazide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Gadobutrol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Gadobutrol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Gadobutrol—Headache—Gliclazide—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadobutrol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadobutrol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Gadobutrol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Gadobutrol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Gadobutrol—Dizziness—Valsartan—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Gadobutrol—Dizziness—Orlistat—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Gadobutrol—Nausea—Gliclazide—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Gadobutrol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Gadobutrol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Gadobutrol—Vomiting—Valsartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Gadobutrol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Gadobutrol—Rash—Valsartan—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Gadobutrol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadobutrol—Vomiting—Orlistat—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadobutrol—Insomnia—Ramipril—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadobutrol—Headache—Valsartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Gadobutrol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Gadobutrol—Rash—Orlistat—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Gadobutrol—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Gadobutrol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Gadobutrol—Headache—Orlistat—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Gadobutrol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Gadobutrol—Dizziness—Metformin—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Gadobutrol—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Gadobutrol—Nausea—Valsartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Gadobutrol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Gadobutrol—Nausea—Orlistat—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Gadobutrol—Vomiting—Metformin—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Gadobutrol—Rash—Metformin—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Gadobutrol—Dermatitis—Metformin—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Gadobutrol—Headache—Metformin—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Gadobutrol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Gadobutrol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Gadobutrol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Gadobutrol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Gadobutrol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Gadobutrol—Rash—Irbesartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Gadobutrol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Gadobutrol—Nausea—Metformin—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Gadobutrol—Headache—Irbesartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Gadobutrol—Dizziness—Losartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Gadobutrol—Vomiting—Losartan—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Gadobutrol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Gadobutrol—Nausea—Irbesartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Gadobutrol—Rash—Losartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Gadobutrol—Dermatitis—Losartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Gadobutrol—Headache—Losartan—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Gadobutrol—Nausea—Losartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Gadobutrol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Gadobutrol—Dizziness—Ramipril—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Gadobutrol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000983	0.000983	CcSEcCtD
Gadobutrol—Rash—Ramipril—type 2 diabetes mellitus	0.000975	0.000975	CcSEcCtD
Gadobutrol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000974	0.000974	CcSEcCtD
Gadobutrol—Headache—Ramipril—type 2 diabetes mellitus	0.000969	0.000969	CcSEcCtD
Gadobutrol—Nausea—Ramipril—type 2 diabetes mellitus	0.000919	0.000919	CcSEcCtD
